Multiple Myeloma: Choosing the best treatment regimen in newly diagnosed patients - Part 1

December 06, 2023 00:20:43
Multiple Myeloma: Choosing the best treatment regimen in newly diagnosed patients - Part 1
COR2ED - Oncology Medical Conversation
Multiple Myeloma: Choosing the best treatment regimen in newly diagnosed patients - Part 1

Dec 06 2023 | 00:20:43

/

Show Notes

In this medical education podcast series, myeloma experts Dr. Joshua Richter (Assistant Professor of Medicine and Director of Myeloma at the Tisch Cancer Institute at the Icahn School of Medicine and the Blavatnik Family Chelsea Medical Center at Mount Sinai in New York, USA) and Dr. Karthik Ramasamy (Haematologist and Associate Professor of Haematology at the Oxford University Hospitals in London, UK) discuss their experience and views on choosing the best treatment every time in multiple myeloma.

In this first episode, Dr. Richter and Dr. Ramasamy discuss how to select the best approach in newly diagnosed patients with multiple myeloma. The experts look at transplant eligibility as one of the key factors in deciding which treatment to start with in the front-line setting. They discuss the potential for personalising therapy in newly diagnosed patients, both in the transplant setting as well as in patients who are not eligible for transplantation.

They also comment on the impact of MRD negativity in clinical practice and agree that the goal of treatment is to induce deep remissions. However, which patient needs triple or quadruplet therapy to achieve this goal is still unclear and the risk-benefit profile needs to be considered for each individual patient.

The final topic that the experts share their points of view on is continuous vs fixed-duration maintenance therapy.

Other Episodes

Episode

December 06, 2023 00:29:25
Episode Cover

Advanced HCC: 2nd line treatment and the right time to switch

Prof. Dr Amit Singal, Gastroenterologist and Hepatologist at UT Southwestern Medical Center, USA and Prof. Dr Jeroen Dekervel, GI Oncologist at UZ Leuven, Belgium,...

Listen

Episode

December 06, 2023 00:21:28
Episode Cover

Upper GI cancer: Update from ESMO 2022 - Part 2

This second GI CONNECT podcast episode, covers the highlights on gastroesophageal cancer from ESMO 2022.  Dr Sam Klempner (Massachusetts General Hospital, Boston, USA) and...

Listen

Episode

December 06, 2023 00:26:43
Episode Cover

Prostate cancer: PARP inhibitors in prostate cancer

COR2ED Medical Education: Dr Jason Alcorn, nurse consultant for Uro-Oncology & Andrology at the Mid Yorkshire Hospitals NHS Trust, United Kingdom and Dr Alicia...

Listen